Investment Summary |
|
|---|---|
| Date | 2022-11-02 |
| Target | Compass Therapeutics |
| Sector | Life Science |
| Investor(s) | Enavate Sciences |
| Deal Type | Stake Purchase |
SEARCH BY
Enavate Sciences is a platform dedicated to supporting therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient need. Through the application of capital support and operational experience, Enavate strives to enable and empower a diverse portfolio of therapeutics companies to accelerate innovation. Enavate Sciences is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Stake Purchase M&A Deals | 1 of 1 |
| Country: United Kingdom M&A | 1 of 1 |
| Year: 2022 M&A | 1 of 1 |